RPGLIFE

What RPG Life Sciences promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q4 FY26

what the last two calls moved 13 tracked 2 delivered 4 missed 7 open
  • API Plant Restoration delivered said Q4 FY25 Promised: Restoration by September/October, normalization from H2 FY26 Q4 FY26: The API segment demonstrated a strong recovery in Q4 with revenues of INR 33.3 crores (144% growth) and management confirmed margin stabilization has started, indicating the plant is fully operational and business normalized in H2 FY26 as targeted.
  • Domestic Market Value Growth missed said Q4 FY25 Promised: mid-teens for FY26 Q4 FY26: Full year FY26 domestic formulation growth was 13.7%. This is slightly below the 'mid-teens' (14-16%) guidance.
  • New API Molecules Pipeline on track said Q4 FY25 Promised: around 12 by end FY26 and FY27 Q4 FY26: Management confirmed the API pipeline has expanded to 13 products, aligning with the target of launching ~12 new molecules by the end of FY26/FY27.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 13 tracked commitments for RPG Life Sciences — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens